Representative before the EPO

Technology company logo thumb
no operation time available
2 offices
Technology Company

We have observed 5 EP applications Anne Julia Meinel has served for within the last five+ years. (We consider all applications which have an EP A1 or A2 publication dated after November 17, 2014). Please note, that we only count EP applications, in which the name of the patent attorney is explicitly mentioned as representative. These EP applications are:

EP16205568

SYSTEM AND METHOD FOR DETERMINING THE CONCENTRATION OF AN ANALYTE IN A SAMPLE FLUID

IPC classification:
G01N 27/327, G01N 33/487, G01N 33/49
Applicant:
Roche Diabetes Care GmbH
Applicant:
F. Hoffmann-La Roche AG
Agent:
Anne Julia Meinel, Roche Diabetes Care GmbH
Status:
Request for examination was made
EP17170521

ELECTRICAL PATTERNS FOR BIOSENSOR AND METHOD OF MAKING

IPC classification:
G01N 33/487, G01N 27/30, C12Q 1/00
Applicant:
Roche Diabetes Care GmbH
Applicant:
F. Hoffmann-La Roche AG
Agent:
Anne Julia Meinel, Roche Diabetes Care GmbH
Status:
Request for examination was made
EP16206479

GLUCOSE DEHYDROGENASE VARIANTS WITH IMPROVED PROPERTIES

IPC classification:
C12N 15/52, C12N 9/04
Applicant:
Roche Diabetes Care GmbH
Applicant:
F. Hoffmann-La Roche AG
Agent:
Anne Julia Meinel, Roche Diabetes Care GmbH
Status:
The application has been published
EP18166016

GENETICALLY ENGINEERED PYRROLOQUINOLINE QUINONE DEPENDENT GLUCOSE DEHYDROGENASE COMPRISING AN AMINO ACID INSERTION

IPC classification:
C12M 1/40, C12N 15/53, C12N 15/10, G01N 33/66, C12Q 1/32, C12N 9/04
Applicant:
Roche Diabetes Care GmbH
Applicant:
F. Hoffmann-La Roche AG
Agent:
Anne Julia Meinel, Roche Diabetes Care GmbH
Status:
The application has been published
EP17832074

GLUCOSE DEHYDROGENASE VARIANTS WITH IMPROVED PROPERTIES

IPC classification:
C12N 15/52, C12N 9/04
Applicant:
F. Hoffmann-La Roche AG
Applicant:
Roche Diabetes Care GmbH
Agent:
Anne Julia Meinel, Roche Diabetes Care GmbH
Status:
Request for examination was made

Please Sign in to use this feature